WA
DXCM icon

Whipplewood Advisors’s DexCom DXCM Stock Holding History

Whipplewood Advisors’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-91
Closed -$5.71K – 766
2026
Q1 		$5.71K Buy
91
+83
+1,038% +$5.78K ﹤0.01% 586
2025
Q4 		$531 Buy
+8
New +$517 ﹤0.01% 456
2025
Q3 		– Sell
-138
Closed -$12K – 554
2025
Q2 		$12K Sell
138
-126
-48% -$9.88K 0.01% 536
2025
Q1 		$9.22K Buy
264
+148
+128% +$12.1K 0.01% 577
2024
Q4 		$9.02K Buy
+116
New +$8.59K 0.01% 571

Other funds holding DXCM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Whipplewood Advisors's DXCM Position: Q2 2026 in Review

Whipplewood Advisors sold out of DexCom (DXCM) in Q2 2026, closing a stake of 91 shares — an estimated $5.71K sold.

Whipplewood Advisors first reported a position in DXCM in Q4 2024 and held it in 5 quarters. The position peaked at $12K in Q2 2025. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Whipplewood Advisors reported no remaining DexCom position as of Q2 2026 after selling out during the quarter.
  • Whipplewood Advisors sold 91 DexCom shares in Q2 2026, an estimated $5.71K.
  • Whipplewood Advisors first reported a position in DexCom in Q4 2024 and held it in 5 quarters.
  • Whipplewood Advisors's DexCom position peaked at $12K in Q2 2025.
  • 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Whipplewood Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.